An adaptive randomised placebo controlled phase II trial of antivirals for COVID-19 infection (VIRCO): A structured summary of a study protocol for a randomised controlled trial

An adaptive randomised placebo controlled phase II trial of antivirals for COVID-19 infection (VIRCO): A structured summary of a study protocol for a randomised controlled trial

Abstract Objectives Primary objective: To determine the efficacy of a candidate antiviral on time to virological cure compared to standard of care within 14 days of randomisation Secondary objectives: • To determine the safety of the antiviral • To determine the clinical benefit of the antiviral ove...

Full description

Bibliographic Details
Main Authors: James H. McMahon, Jillian S. Y. Lau, Janine Roney, Benjamin A. Rogers, Jason Trubiano, Joseph Sasadeusz, James S. Molton, Bradley Gardiner, Sue J. Lee, Jennifer F. Hoy, Allen Cheng, Anton Y. Peleg
Format: Article
Language:English
Published: BMC 2020-10-01
Series:Trials
Subjects:
COVID-19
Randomised controlled trial
protocol
favipiravir
treatment
community
Online Access:http://link.springer.com/article/10.1186/s13063-020-04766-5

Internet

http://link.springer.com/article/10.1186/s13063-020-04766-5

Similar Items